Financials

  • Market Capitalization 89.27 M
  • Employee 7
  • Founded 2018
  • CEO N/A
  • Website www.rallybio.com
  • Headquarter Delaware, United States
  • FIGI BBG011PFKF54
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.45
Rapporto prezzo/fatturato
36.01

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3980
ICCC
ImmuCell Corporation - Common Stock
9.94 USD-0.80%-1.19%-9.72%+58.03%90.28 M USD
3986
ALDX
Aldeyra Therapeutics, Inc. - Common Stock
1.49 USD-3.25%-2.61%-8.59%-74.40%89.89 M USD
3998
ACRV
Acrivon Therapeutics, Inc. - Common Stock
2.06 USD-4.19%-5.94%+44.06%+57.25%88.28 M USD
4011
LNAI
Lunai Bioworks Inc. - Common Stock
2.37 USD+0.85%+9.72%+15.05%+52.90%85.96 M USD

Notizie